Osteitis Fibrosa Cystica Explained

Osteitis fibrosa cystica, also known as von Recklinghausen disease of bone, is a skeletal disorder characterized by excessive bone resorption, fibrosis, and the development of "brown tumors" (cystic lesions composed of osteoclasts, hemorrhage, and fibrous tissue).

Osteitis Fibrosa Cystica and Hyperparathyroidism

This condition is a classic manifestation of hyperparathyroidism, particularly primary hyperparathyroidism caused by a parathyroid adenoma or hyperplasia. The overactive parathyroid glands secrete excess parathyroid hormone (PTH).

• Role of PTH: PTH increases osteoclast activity, leading to increased bone resorption. It also affects calcium and phosphate metabolism, causing high levels of calcium (hypercalcemia) and low levels of phosphate (hypophosphatemia) in the blood.
• Pathology: The persistent stimulation of bone resorption by high PTH levels results in weakened bones, increased marrow fibrosis, and the characteristic cystic lesions of osteitis fibrosa cystica.

Incorrect Options Analysis

• Hyperthyroidism: While it affects bone metabolism, it typically causes increased bone turnover and osteoporosis, not osteitis fibrosa cystica.
• Milk-alkali syndrome: Associated with hypercalcemia, but primarily affects kidneys and calcium-alkali balance, not typically causing this specific bone pathology.
• Rickets: A disorder of bone mineralization in children (osteomalacia in adults), caused by vitamin D deficiency or impaired metabolism, leading to soft, weak bones, distinct from osteitis fibrosa cystica.

Therefore, osteitis fibrosa cystica is a hallmark sign of hyperparathyroidism.